AR099556A1 - Implante que contiene fgf-18 - Google Patents

Implante que contiene fgf-18

Info

Publication number
AR099556A1
AR099556A1 ARP150100505A ARP150100505A AR099556A1 AR 099556 A1 AR099556 A1 AR 099556A1 AR P150100505 A ARP150100505 A AR P150100505A AR P150100505 A ARP150100505 A AR P150100505A AR 099556 A1 AR099556 A1 AR 099556A1
Authority
AR
Argentina
Prior art keywords
delivery system
implants
implant containing
fgf
containing fgf
Prior art date
Application number
ARP150100505A
Other languages
English (en)
Inventor
H Ladel Christoph
Guehring Hans
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR099556A1 publication Critical patent/AR099556A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817Cartilage-forming cells, e.g. pre-chondrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un sistema de suministro de sustancias (o implantes), tales como scaffolds y membranas que contienen un fármaco anabólico, tal como un compuesto del Factor de Crecimiento de Fibroblastos 18 (FGF-18), a los métodos para producir tales sistemas de suministro, así como al uso de los mismos. Los implantes son para su uso para el tratamiento de trastornos del cartílago, tales como la osteoartritis, la lesión del cartílago o los defectos osteocondrales. Reivindicación 4: El sistema de suministro de sustancias de acuerdo con una cualquiera de las reivindicaciones 1 a 3, en el que, por lo menos, un material polimérico es una combinación de colágeno y de glicosaminoglicanos (GAG). Reivindicación 5: El sistema de suministro de sustancias de acuerdo con. cualquiera cha las reivindicaciones anteriores, que contiene además células condrogénicas.
ARP150100505A 2014-02-20 2015-02-20 Implante que contiene fgf-18 AR099556A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14000598 2014-02-20

Publications (1)

Publication Number Publication Date
AR099556A1 true AR099556A1 (es) 2016-08-03

Family

ID=50151086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100505A AR099556A1 (es) 2014-02-20 2015-02-20 Implante que contiene fgf-18

Country Status (24)

Country Link
US (1) US10086112B2 (es)
EP (1) EP3107592B1 (es)
JP (1) JP6510547B2 (es)
KR (1) KR102421950B1 (es)
CN (1) CN106232154A (es)
AR (1) AR099556A1 (es)
AU (1) AU2015220785B2 (es)
BR (1) BR112016018681B1 (es)
CA (1) CA2938796C (es)
DK (1) DK3107592T3 (es)
ES (1) ES2698117T3 (es)
HR (1) HRP20181573T1 (es)
IL (1) IL247106B (es)
LT (1) LT3107592T (es)
MX (1) MX368946B (es)
NZ (1) NZ723177A (es)
PL (1) PL3107592T3 (es)
PT (1) PT3107592T (es)
RS (1) RS58138B1 (es)
RU (1) RU2700414C2 (es)
SG (1) SG11201606697YA (es)
SI (1) SI3107592T1 (es)
WO (1) WO2015124739A1 (es)
ZA (1) ZA201605667B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX346385B (es) 2013-02-14 2017-03-16 Nanopareil Llc Fieltros hibridos de nanofibras electrohiladas.
MX2016010872A (es) 2014-02-20 2016-11-17 Merck Patent Gmbh Regimen de dosificacion del compuesto de factor de crecimiento de fibroblastos 18.
CN117187255B (zh) * 2023-11-07 2024-01-30 北京大学第三医院(北京大学第三临床医学院) 编码FGF18或rhFGF18的mRNA及其在骨关节炎治疗中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69714035T2 (de) * 1997-08-14 2003-03-06 Sulzer Innotec Ag, Winterthur Zusammensetzung und Vorrichtung zur Reparatur von Knorpelgewebe in vivo bestehend aus Nanokapseln mit osteoinduktiven und/oder chondroinduktiven Faktoren
US6511958B1 (en) * 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
KR100380119B1 (ko) * 2001-04-19 2003-04-11 한국항공우주연구원 이원화된 통신속도 적응형 베이스 밴드 스위칭 위상시프트 키잉 장치
EP1273365A1 (fr) * 2001-07-06 2003-01-08 Recherche Et Developpement Du Groupe Cockerill Sambre Outils rotatifs pour le perçage en ligne de produits profiles
ES2493840T3 (es) * 2002-10-07 2014-09-12 Zymogenetics, Inc. Procedimiento de administración de FGF-18
US8852240B2 (en) * 2004-10-25 2014-10-07 Kieran Murphy, Llc Methods and compositions for fostering and preserving bone growth
US7858341B2 (en) * 2004-12-10 2010-12-28 Zymogenetics, Inc. FGF18 production in prokaryotic hosts
RS52710B (en) * 2006-08-25 2013-08-30 Ares Trading S.A. Treatment of cartilage disorders with FGF-18
WO2010102266A1 (en) * 2009-03-05 2010-09-10 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects
US8431399B2 (en) * 2010-03-02 2013-04-30 Taipei Medical University Method to restore cartilaginous phenotype of chondrocytes after cultured and expanded in vitro
WO2012094511A2 (en) * 2011-01-05 2012-07-12 Rhode Island Hospital Compositions and methods for the treatment of orthopedic disease or injury
EP2678048B1 (en) * 2011-02-22 2018-11-21 Institut National de la Sante et de la Recherche Medicale (INSERM) Nano-reservoirs technology for use in bone and/or cartilage regeneration
US9795714B2 (en) * 2013-12-24 2017-10-24 Ares Trading S.A. FGF-18 formulation in alginate/collagen hydrogels
MX2016010872A (es) 2014-02-20 2016-11-17 Merck Patent Gmbh Regimen de dosificacion del compuesto de factor de crecimiento de fibroblastos 18.
EP3107591B1 (en) 2014-02-20 2018-04-18 Merck Patent GmbH Fgf-18 in graft transplantation and tissue engineering procedures

Also Published As

Publication number Publication date
KR20160124806A (ko) 2016-10-28
AU2015220785A1 (en) 2016-09-01
CA2938796A1 (en) 2015-08-27
SG11201606697YA (en) 2016-09-29
MX2016010874A (es) 2016-11-17
PT3107592T (pt) 2018-12-03
HRP20181573T1 (hr) 2018-11-30
LT3107592T (lt) 2018-12-10
SI3107592T1 (sl) 2018-11-30
US20170056560A1 (en) 2017-03-02
IL247106B (en) 2020-02-27
CN106232154A (zh) 2016-12-14
JP2017507145A (ja) 2017-03-16
KR102421950B1 (ko) 2022-07-18
AU2015220785B2 (en) 2018-07-19
BR112016018681A2 (pt) 2017-10-17
RU2700414C2 (ru) 2019-09-17
EP3107592A1 (en) 2016-12-28
RU2016137291A (ru) 2018-03-21
PL3107592T3 (pl) 2019-02-28
NZ723177A (en) 2021-12-24
US10086112B2 (en) 2018-10-02
CA2938796C (en) 2022-08-02
MX368946B (es) 2019-10-22
IL247106A0 (en) 2016-09-29
WO2015124739A1 (en) 2015-08-27
JP6510547B2 (ja) 2019-05-08
ZA201605667B (en) 2018-12-19
BR112016018681B1 (pt) 2021-01-05
RS58138B1 (sr) 2019-02-28
RU2016137291A3 (es) 2018-08-28
DK3107592T3 (en) 2018-11-12
EP3107592B1 (en) 2018-08-22
ES2698117T3 (es) 2019-01-31

Similar Documents

Publication Publication Date Title
DOP2017000128A (es) Nuevas normalizaciones y dispositivos médicos para la preparación de plasma rico en plaquetas (prp) o concentrado de médula ósea (bmc) solos o combinados con ácido hialurónico
UY36852A (es) Derivados de triazol novedosos
CL2018001868A1 (es) Análogos del egf(a) con sustituyentes de ácidos grasos.
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
CR20160501A (es) Derivados de quinoxalina útiles como amortiguadores del receptor del factor de crecimiento de fibroblastos (fgfr) cinasa
CL2014000566A1 (es) Compuestos derivados de pirrolopirimidina y purina, y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende, util para el tratamiento del crecimiento celular anormal, tal como cancer.
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
BR112016022553A2 (pt) Compostos e métodos para entrega transmembrana de moléculas?
UY36118A (es) Compuestos y composiciones para inducir condrogénesis
AR104984A1 (es) Compuestos selectivos para pyy y sus usos
ECSP18073293A (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue
EA201401046A1 (ru) Устройство и способы печати биологических тканей и органов
PE20151499A1 (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico
CO6771417A2 (es) Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis
BR122021026889A8 (pt) Formas cristalinas de base livre de sepiapterina e de sais dos mesmos, seu método de preparação, composições que as compreendem, uso dos mesmos e método de preparação de uma formulação líquida
AR101742A1 (es) Agonista del receptor de calcitonina y amilina
BR112017025711A2 (pt) ?composições, processo para preparação de siloxanos modificados por poliéter e uso das composições inovadoras?
EP4364799A3 (en) Mesenchymal stem cell-derived extracellular vesicles and their medical use
MX2020009237A (es) Composiciones inyectables de reparacion de cartilagos, tendones y ligamentos fuera del estante y metodos de uso.
CL2018001085A1 (es) Derivados de indolin-2-ona
ECSP14013157A (es) Formulaciones liofilizadas de fgf-18
AR099556A1 (es) Implante que contiene fgf-18
AR099558A1 (es) Régimen de dosaje del compuesto fgf-18
BR112016018704A2 (pt) fgf-18 em procedimentos de transplante de enxerto e de engenheiramento de tecido
CL2016003095A1 (es) Péptidos como agonistas de la oxitocina

Legal Events

Date Code Title Description
FC Refusal